Other OTC - Delayed Quote USD

ManifestSeven Holdings Corporation (MNFSF)

0.0000 0.0000 (0.00%)
At close: April 1 at 1:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
11/30/2020
Total Revenue
15,785.9660
17,743.3010
Cost of Revenue
10,988.9730
12,214.5290
Gross Profit
4,796.9930
5,528.7720
Operating Expense
39,055.7350
41,546.1560
Operating Income
-34,258.7420
-36,017.3840
Net Non Operating Interest Income Expense
-10,499.2160
-11,742.9710
Other Income Expense
4,705.8170
-18,747.6890
Pretax Income
-40,052.1410
-66,508.0440
Net Income Common Stockholders
-39,955.4740
-66,411.3770
Diluted NI Available to Com Stockholders
-39,955.4740
-66,411.3770
Basic EPS
-0.27
-0.78
Diluted EPS
-0.27
-0.78
Basic Average Shares
145,855.1390
85,378.2090
Diluted Average Shares
145,855.1390
85,378.2090
Total Operating Income as Reported
-34,258.7420
-36,017.3840
Total Expenses
50,044.7080
53,760.6850
Net Income from Continuing & Discontinued Operation
-39,955.4740
-66,411.3770
Normalized Income
-45,140.9720
-48,084.4650
Interest Expense
10,499.2160
11,742.9710
Net Interest Income
-10,499.2160
-11,742.9710
EBIT
-29,552.9250
-54,765.0730
EBITDA
-27,297.5440
-52,542.4730
Reconciled Cost of Revenue
11,044.1670
12,214.5290
Reconciled Depreciation
2,200.1870
2,222.6000
Net Income from Continuing Operation Net Minority Interest
-39,955.4740
-66,411.3770
Total Unusual Items Excluding Goodwill
5,185.4980
-18,326.9120
Total Unusual Items
5,185.4980
-18,326.9120
Normalized EBITDA
-32,483.0420
-34,215.5610
11/30/2020 - 10/5/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ITHUF iAnthus Capital Holdings, Inc.
0.0192
+1.86%
 
TGIFF 1933 Industries Inc.
0.0110
0.00%
 
FFNTF 4Front Ventures Corp.
0.0968
+7.32%
 
MMNFF MedMen Enterprises Inc.
0.0000
0.00%
 
EBS Emergent BioSolutions Inc.
2.1600
+5.88%
 
MJNA Medical Marijuana, Inc.
0.0020
-4.76%
 
TAK Takeda Pharmaceutical Company Limited
13.36
+0.91%
 
TEVA Teva Pharmaceutical Industries Limited
12.88
+0.16%
 
ACB Aurora Cannabis Inc.
6.28
-2.79%